Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.70
+0.07 (1.24%)
Dec 20, 2024, 4:00 PM EST - Market closed
Abeona Therapeutics Employees
Abeona Therapeutics had 84 employees as of December 31, 2023. The number of employees increased by 27 or 47.37% compared to the previous year.
Employees
84
Change (1Y)
27
Growth (1Y)
47.37%
Revenue / Employee
n/a
Profits / Employee
-$845,619
Market Cap
247.78M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
High Tide | 1,550 |
Anika Therapeutics | 357 |
Lexicon Pharmaceuticals | 285 |
Pulmonx | 279 |
Heron Therapeutics | 126 |
Fulcrum Therapeutics | 76 |
Rezolute | 51 |
Larimar Therapeutics | 42 |
ABEO News
- 5 weeks ago - Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 5 weeks ago - Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa - GlobeNewsWire
- 6 weeks ago - Abeona Therapeutics® Announces Participation in November Investor Conferences - GlobeNewsWire
- 7 weeks ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 7 weeks ago - Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration - GlobeNewsWire
- 2 months ago - Abeona Therapeutics Targets RDEB Market With Promising Pz-cel Therapy - Seeking Alpha
- 3 months ago - Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - GlobeNewsWire